Elysium Health seeks to help people live healthier, longer. Through extensive scientific research performed by world-class scientists, the company has continually pursued the goal of translating advances in science and technology into clinically validated health products that work.
Founding the Company
Elysium Health was founded in 2014 by Dr. Leonard Guarente. As the Chief Scientist of Elysium Health, and the Director of Glen Laboratory for Science of Aging at MIT, he holds substantial knowledge in the field of genetic and molecular causes of aging.
Eric Marcotulli and Dan Alminana helped Dr. Guarente found the company, becoming the CEO and the COO of Elysium Health. Their experience comes from venture capital and investment banking industries.
Proven Clinical Results
Basis is a supplement that is based on 25 years of prior clinical research. The supplement’s primary purpose is to support long-term cellular well-being by increasing and sustaining levels of NAD+. NAD+ is a coenzyme that is required for many essential cellular functions. Over time, levels of NAD+ tend to decline in our cells, but Basis is clinically proven to increase levels of NAD+ in humans by an average of 40%.
During the clinical trial, 120 people were divided into three groups. One group received a placebo, the second group received two capsules of Basis daily (the recommended daily amount), and the third group received four capsules of Basis daily (double the recommended daily amount). After several weeks, the group taking two capsules of Basis per day saw an increase in NAD+ levels of an average of 40 percent.
Elysium Health is in the process of researching new products that focus on the microbiome, cognitive health, skin health, muscle function, and circadian rhythms. These products are in various stages of pre-clinical and clinical trials.
For more information about Basis or Elysium Health, visit Elysium Health’s website.